Rc/CMV cyclin E Citations (6)
Originally described in: Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA Cell. 1992 Sep 18. 70(6):993-1006. PubMed Journal
Articles Citing Rc/CMV cyclin E
| Articles |
|---|
| Slug is temporally regulated by cyclin E in cell cycle and controls genome stability. Wang WL, Huang HC, Kao SH, Hsu YC, Wang YT, Li KC, Chen YJ, Yu SL, Wang SP, Hsiao TH, Yang PC, Hong TM. Oncogene. 2015 Feb 26;34(9):1116-25. doi: 10.1038/onc.2014.58. Epub 2014 Mar 24. PubMed |
| The cyclin-like protein, SPY1, regulates the ERalpha and ERK1/2 pathways promoting tamoxifen resistance. Ferraiuolo RM, Tubman J, Sinha I, Hamm C, Porter LA. Oncotarget. 2017 Apr 4;8(14):23337-23352. doi: 10.18632/oncotarget.15578. PubMed |
Rapid DNA replication origin licensing protects stem cell pluripotency.
Matson JP, Dumitru R, Coryell P, Baxley RM, Chen W, Twaroski K, Webber BR, Tolar J, Bielinsky AK, Purvis JE, Cook JG.
Elife. 2017 Nov 17;6. doi: 10.7554/eLife.30473.
PubMed
Associated Plasmids |
| Overexpression of Cyclin E1 or Cdc25A leads to replication stress, mitotic aberrancies, and increased sensitivity to replication checkpoint inhibitors. Kok YP, Guerrero Llobet S, Schoonen PM, Everts M, Bhattacharya A, Fehrmann RSN, van den Tempel N, van Vugt MATM. Oncogenesis. 2020 Oct 7;9(10):88. doi: 10.1038/s41389-020-00270-2. PubMed |
| Stabilization of c-Myc by the atypical cell cycle regulator, Spy1, decreases efficacy of breast cancer treatments. Ferraiuolo RM, Fifield BA, Hamm C, Porter LA. Breast Cancer Res Treat. 2022 Nov;196(1):17-30. doi: 10.1007/s10549-022-06715-z. Epub 2022 Aug 27. PubMed |
| Insights into the SARS-CoV-2 ORF6 Mechanism of Action. Krachmarova E, Petkov P, Lilkova E, Ilieva N, Rangelov M, Todorova N, Malinova K, Hristova R, Nacheva G, Gospodinov A, Litov L. Int J Mol Sci. 2023 Jul 18;24(14):11589. doi: 10.3390/ijms241411589. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.